Related Experiment Videos
Capsules, infection, and intraluminal antibiotics
Plastic and Reconstructive Surgery
|July 1, 1981
Summary
This study suggests Staphylococcus epidermidis may cause breast implant capsular contracture. Using intraluminal antibiotics cephalothin and gentamicin significantly reduced contracture incidence in patients.
Area of Science:
- Plastic Surgery
- Microbiology
- Biomaterials Science
Background:
- Staphylococcus epidermidis is a common skin bacterium found in nipple secretions and around breast implants.
- High percentages of fibrous capsules and surgical pockets show S. epidermidis presence.
- Capsular contracture is a common complication following breast augmentation surgery.
Purpose of the Study:
- To investigate the role of Staphylococcus epidermidis in breast implant capsular contracture.
- To evaluate the efficacy of intraluminal antibiotics in preventing capsular contracture.
Main Methods:
- Antibiotics (cephalothin and gentamicin) were placed within the lumen of breast implants.
- Antibiotic diffusion through the silicone shell was assessed in vitro.
- The incidence of capsular contracture was compared between patients receiving intraluminal antibiotics and those who did not.
Main Results:
- Cephalothin and gentamicin diffused through the silicone implant shell.
- Intraluminal antibiotic use significantly reduced capsular contracture rates after primary augmentation and secondary capsulotomy.
- This suggests a potential link between low-grade periprosthetic infection and contracture.
Conclusions:
- A low-grade periprosthetic infection may be the cause of fibrous capsular contracture.
- The silicone shell's permeability allows sustained antimicrobial activity, potentially preventing contracture.
- Intraluminal antibiotic delivery is a promising strategy to reduce breast implant complications.